Suchergebnisse - "145155-23-3"

PubPharm (149)

1

Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis : a network meta-analysis

enthalten in: The Cochrane database of systematic reviews | 2024

von Gonzalez-Lorenzo, M. | Ridley, B. | Minozzi, S. | +8

UpdateOf: Cochrane Database Syst Rev. 2015 Sep 18;(9):CD011381. - PMID 26384035

2

Adverse effects of immunotherapies for multiple sclerosis : a network meta-analysis

enthalten in: The Cochrane database of systematic reviews | 2023

von Tramacere, I. | Virgili, G. | Perduca, V. | +8

3

Comparative Efficacy of Relapsing Multiple Sclerosis Therapies : Model-Based Meta-Analyses for Confirmed Disability Accumulation and Annualized Relapse Rate

enthalten in: Multiple sclerosis and related disorders | 2022

von Hennessy, B. | Zierhut, M. | Kracker, H. | +2

4

Beneficial Effect of Melatonin Alone or in Combination with Glatiramer Acetate and Interferon β-1b on Experimental Autoimmune Encephalomyelitis

enthalten in: Molecules (Basel, Switzerland) | 2022

von Ortíz, G. | Briones-Torres, A. | Benitez-King, G. | +3

5

TnP Peptide Suppresses Experimental Autoimmune Encephalomyelitis (EAE) in a Preclinical Mouse Model

enthalten in: Frontiers in immunology | 2022

von Lima, C. | Maleski, A. | Bernardo, J. | +3

6

Oxidative stress activity of fingolimod in multiple sclerosis

enthalten in: Clinical neurology and neurosurgery | 2021

von Yevgi, R. | Demir, R.

7

A case report with tuberculous meningitis during fingolimod treatment

enthalten in: Multiple sclerosis and related disorders | 2020

von Köseoğlu, M. | Gözübatık Çelik, R. | Kürtüncü, M.

8

Long-term follow-up of multiple sclerosis studies and outcomes from early treatment of clinically isolated syndrome in the BENEFIT 11 study

enthalten in: Journal of neurology | 2020

von Hartung, H. | Graf, J. | Kremer, D.

9

Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis : Effect on clinical and MRI outcomes

enthalten in: Multiple sclerosis and related disorders | 2019

von Yano, H. | Gonzalez, C. | Healy, B. | +3

10

Assessment of CCL27 and IL-11 in Multiple Sclerosis Patients Treated with Interferon-β and Glatiramer Acetate

enthalten in: Neuroimmunomodulation | 2019

von Ebrahimi Monfared, M. | Shapoori, S. | Mosayebi, G. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]